|
VGLL4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93045579521822E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.35430000050663E-07 |
| Normal-vs-Stage2 |
2.875300E-03 |
| Normal-vs-Stage3 |
1.950040E-01 |
| Normal-vs-Stage4 |
3.650800E-01 |
| Stage1-vs-Stage2 |
1.016800E-01 |
| Stage1-vs-Stage3 |
3.439200E-03 |
| Stage1-vs-Stage4 |
8.966200E-04 |
| Stage2-vs-Stage3 |
1.731420E-01 |
| Stage2-vs-Stage4 |
1.044040E-01 |
| Stage3-vs-Stage4 |
7.090800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.65580052078485E-10 |
| Normal-vs-AfricanAmerican |
2.85989999460057E-08 |
| Normal-vs-Asian |
6.677400E-01 |
| Caucasian-vs-AfricanAmerican |
2.591400E-01 |
| Caucasian-vs-Asian |
3.492800E-01 |
| AfricanAmerican-vs-Asian |
1.293410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.99200722162641E-16 |
| Normal-vs-Female |
1.261240E-03 |
| Male-vs-Female |
2.894600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.539600E-02 |
| Normal-vs-Extreme_Weight |
1.210370E-04 |
| Normal-vs-Obese |
5.43179999978882E-07 |
| Normal-vs-Extreme_Obese |
1.155730E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.353800E-01 |
| Normal_Weight-vs-Obese |
9.485400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.436200E-01 |
| Extreme_Weight-vs-Obese |
2.972000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.642400E-01 |
| Obese-vs-Extreme_Obese |
5.955000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.324350E-02 |
| Normal-vs-Age(41-60Yrs) |
1.289399999993E-06 |
| Normal-vs-Age(61-80Yrs) |
2.47220022231431E-11 |
| Normal-vs-Age(81-100Yrs) |
5.618000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.549820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.119800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.006000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.836400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.105700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.679600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.11022302462516E-16 |
| Normal-VS-Type2 PRCC |
3.723200E-01 |
| Normal-VS-KIRP CIMP |
5.199200E-01 |
| Normal-VS-Unclassified PRCC |
3.953000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.76398912038667E-12 |
| Type1 PRCC-VS-KIRP CIMP |
1.85629955851141E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
5.223800E-04 |
| Type2 PRCC-VS-KIRP CIMP |
8.126200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.440600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.617700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.635200E-03 |
| Normal-vs-N1 |
2.567000E-01 |
| Normal-vs-N2 |
2.163500E-02 |
| N0-vs-N1 |
3.467800E-01 |
| N0-vs-N2 |
8.893200E-01 |
| N1-vs-N2 |
5.373800E-01 |
|
|
